Living with hypertrophic cardiomyopathy: A patient's perspective

Hypertrophic cardiomyopathy (HCM) is a complex disease characterized by thickening of the cardiac muscle. Common symptoms include chest pain, shortness of breath, palpitations, fatigue and syncope (fainting), which are often confused for other conditions. Clinical treatment focuses on the relief of...

Full description

Bibliographic Details
Main Authors: Borsari, W. (Author), Davis, L. (Author), McDonough, B. (Author), Meiers, E. (Author), Salberg, L. (Author)
Format: Article
Language:English
Published: Future Medicine Ltd. 2022
Subjects:
Online Access:View Fulltext in Publisher
LEADER 03666nam a2200937Ia 4500
001 10-2217-fca-2021-0091
008 220420s2022 CNT 000 0 und d
020 |a 14796678 (ISSN) 
245 1 0 |a Living with hypertrophic cardiomyopathy: A patient's perspective 
260 0 |b Future Medicine Ltd.  |c 2022 
300 |a 8 
856 |z View Fulltext in Publisher  |u https://doi.org/10.2217/fca-2021-0091 
520 3 |a Hypertrophic cardiomyopathy (HCM) is a complex disease characterized by thickening of the cardiac muscle. Common symptoms include chest pain, shortness of breath, palpitations, fatigue and syncope (fainting), which are often confused for other conditions. Clinical treatment focuses on the relief of symptoms with medical therapies, which provide adequate to more variable symptomatic relief. Patients may experience more severe complications that require surgical intervention, such as implantable cardioverter-defibrillator therapy or septal myectomy. Despite the potential impact on quality of life, the humanistic burden of HCM is not well established. Here, we present four patient testimonials that highlight challenges faced by patients and clinicians in diagnosing HCM and managing symptoms. These testimonials provide valuable information on the spectrum and expression of HCM across generations. Such testimonials can better inform disease diagnosis and monitoring, maximizing quality of life and improving disease outcome. © 2021 The Authors. 
650 0 4 |a acetylsalicylic acid 
650 0 4 |a adolescent 
650 0 4 |a adult 
650 0 4 |a Arrhythmias, Cardiac 
650 0 4 |a Article 
650 0 4 |a atenolol 
650 0 4 |a backache 
650 0 4 |a beta adrenergic receptor blocking agent 
650 0 4 |a Cardiomyopathy, Hypertrophic 
650 0 4 |a cardiovascular magnetic resonance 
650 0 4 |a case report 
650 0 4 |a cerebrovascular accident 
650 0 4 |a child 
650 0 4 |a clinical article 
650 0 4 |a clinician 
650 0 4 |a colecalciferol 
650 0 4 |a Defibrillators, Implantable 
650 0 4 |a diltiazem 
650 0 4 |a dizziness 
650 0 4 |a drug dose increase 
650 0 4 |a dyspnea 
650 0 4 |a echocardiography 
650 0 4 |a emergency ward 
650 0 4 |a endocarditis 
650 0 4 |a faintness 
650 0 4 |a fatigue 
650 0 4 |a female 
650 0 4 |a fluid retention 
650 0 4 |a furosemide 
650 0 4 |a headache 
650 0 4 |a heart arrhythmia 
650 0 4 |a heart left bundle branch block 
650 0 4 |a heart murmur 
650 0 4 |a heart outflow tract obstruction 
650 0 4 |a human 
650 0 4 |a Humans 
650 0 4 |a hypertrophic cardiomyopathy 
650 0 4 |a hypertrophic cardiomyopathy 
650 0 4 |a hypertrophic cardiomyopathy 
650 0 4 |a implantable cardioverter defibrillator 
650 0 4 |a implantable cardioverter defibrillator 
650 0 4 |a knee meniscus rupture 
650 0 4 |a lead fracture 
650 0 4 |a magnesium 
650 0 4 |a middle aged 
650 0 4 |a milrinone 
650 0 4 |a muscle resection 
650 0 4 |a paracetamol 
650 0 4 |a patient care 
650 0 4 |a patient experience 
650 0 4 |a patient monitoring 
650 0 4 |a perception 
650 0 4 |a postoperative pain 
650 0 4 |a quality of life 
650 0 4 |a Quality of Life 
650 0 4 |a school child 
650 0 4 |a septal myectomy 
650 0 4 |a sudden death 
650 0 4 |a thorax pain 
650 0 4 |a verapamil 
650 0 4 |a water retention 
650 0 4 |a wheezing 
700 1 0 |a Borsari, W.  |e author 
700 1 0 |a Davis, L.  |e author 
700 1 0 |a McDonough, B.  |e author 
700 1 0 |a Meiers, E.  |e author 
700 1 0 |a Salberg, L.  |e author 
773 |t Future Cardiology